It can collaborate with TRAIL to stimulate apoptosis in colon cancer, NSCLC, glioma, and several other cancerous cells through two approaches, by increasing the DR5 expression, and by preventing the expression of surviving [93,94]. Here, TNFRSF10B is linked to malignant colon neoplasm.